Evidence map›Paper›PMID 37171822›Full record

ArticleJAMA network open2023

Neurocognitive Analysis of Low-level Arsenic Exposure and Executive Function Mediated by Brain Anomalies Among Children, Adolescents, and Young Adults in India.

Nilakshi Vaidya, Bharath Holla, Jon Heron, Eesha Sharma, Yuning Zhang, Gwen Fernandes, Udita Iyengar, Alex Spiers, Anupa Yadav, Surajit Das and 27 more

Erratum issuedOpen access · goldAbstract readMulticenter Study
In one paragraph

Article in JAMA network open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

37 authors at 14 institutions in 5 countries.

Nilakshi VaidyaCentre for Population Neuroscience and Precision Medicine, Department of Psychiatry and Neuroscience, Charité Universitätsmedizin Berlin, Berlin, Germany.
Bharath HollaDepartment of Psychiatry and Integrative Medicine, National Institute of Mental Health and Neurosciences, Bangalore, India.
Jon HeronCentre for Public Health, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Eesha SharmaDepartment of Child & Adolescent Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India.
Yuning ZhangSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
Gwen FernandesPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Udita IyengarInstitute of Psychology, Psychiatry & Neuroscience, King's College London, London, United Kingdom.
Alex SpiersMRC (Medical Research Council) Centre for Environment and Health, Imperial College London, London, United Kingdom.
Anupa YadavIndian Council of Medical Research-Centre for Ageing and Mental Health, Kolkata, India.
Surajit DasIndian Council of Medical Research-Centre for Ageing and Mental Health, Kolkata, India.
Sanjit RoyIndian Council of Medical Research-Centre for Ageing and Mental Health, Kolkata, India.
Chirag K AhujaDepartment of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Gareth J BarkerDepartment of Neuroimaging, Institute of Psychology, Psychiatry & Neuroscience, King's College London, London, United Kingdom.
Debasish BasuDepartment of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Rose Dawn BharathDepartment of Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neurosciences, Bangalore, India.
Matthew HickmanPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Sanjeev JainDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India.
Kartik KalyanramRishi Valley, Rural Health Centre, India.
Kamakshi KartikRishi Valley, Rural Health Centre, India.
Murali KrishnaFoundation for Research and Advocacy in Mental Health, Mysore, India.
Ghattu KrishnaveniEpidemiology Research Unit, CSI Holdsworth Memorial Hospital, Mysore, India.
Kalyanaraman KumaranEpidemiology Research Unit, CSI Holdsworth Memorial Hospital, Mysore, India.
Rebecca KuriyanDivision of Nutrition, St John's Research Institute, Bangalore, India.
Pratima MurthyDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India.
Dimitri Papadopoulos OrfanosNeuroSpin, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Université Paris-Saclay, Paris, France.
Meera PurushottamMolecular Genetics Laboratory, National Institute of Mental Health and Neurosciences, Bangalore, India.
Sunita Simon KurpadDepartment of Psychiatry, St John's Medical College and Hospital, Bangalore, India.
Lenin SinghRegional Institute of Medical Sciences, Imphal, Manipur, India.
Roshan SinghRegional Institute of Medical Sciences, Imphal, Manipur, India.
B N SubodhDepartment of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Mireille ToledanoMRC (Medical Research Council) Centre for Environment and Health, Imperial College London, London, United Kingdom.
Henrik WalterPsychiatry, Psychiatric Neuroscience and Neurophilosophy, Research Division of Mind and Brain, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Sylvane DesrivièresSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
Amit ChakrabartiIndian Council of Medical Research-Centre for Ageing and Mental Health, Kolkata, India.
Vivek BenegalCentre for Addiction Medicine, National Institute of Mental Health and Neurosciences, Bangalore, India.
Gunter SchumannCentre for Population Neuroscience and Precision Medicine, Department of Psychiatry and Neuroscience, Charité Universitätsmedizin Berlin, Berlin, Germany.
Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA)
National Institute of Mental Health and Neurosciences · INIndian Council of Medical Research · INKing's College London · GBPost Graduate Institute of Medical Education and Research · INUniversity of Bristol · GBCharité - Universitätsmedizin Berlin · DECSI Holdsworth Memorial Hospital · INRegional Institute of Medical Sciences · INCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRFoundation for Research in Community Health · INImperial College London · GBMedical Research Council · GBSt.John's Medical College Hospital · INSt. John's National Academy of Health Sciences · IN

Funding

A decentralized macro and micro gene-by-environment interaction analysis of substance use behavior and its brain biomarkers R01DA049238 · NIDA · GEORGIA STATE UNIVERSITY · PI CALHOUN, VINCE D, LIU, JINGYU · 2019 to 2023
$2.9M
Medical Research Council MC_UP_A620_1016Medical Research Council MC_UU_12011/3Medical Research Council MR/N000390/1Medical Research Council MR/R00465X/1Medical Research Council MR/S020306/1Medical Research Council MR/W002418/1MRF_ MRF-058-0004-RG-DESRIMRF_ MRF-058-0009-RG-DESR-C0759NIDA NIH HHS R01 DA049238
6 · The paper itself

Abstract

Importance: Arsenic, a contaminant of groundwater and irrigated crops, is a global public health hazard. Exposure to low levels of arsenic through food extends well beyond the areas with high arsenic content in water. Objective: To identify cognitive impairments following commonly prevalent low-level arsenic exposure and characterize their underlying brain mechanisms. Design, Setting, and Participants: This multicenter population-based cohort study analyzed cross-sectional data of the Indian Consortium on Vulnerability to Externalizing Disorders and Addictions (cVEDA) cohort, recruited between November 4, 2016, and May 4, 2019. Participants aged 6 to 23 years were characterized using deep phenotyping measures of behavior, neuropsychology, psychopathology, brain neuroimaging, and exposure to developmental adversities and environmental neurotoxins. All analyses were performed between June 1, 2020, and December 31, 2021. Exposure: Arsenic levels were measured in urine as an index of exposure. Main Outcomes and Measures: Executive function measured using the cVEDA neuropsychological battery, gray matter volume (GMV) from T1-weighted magnetic resonance imaging, and functional network connectivity measures from resting state functional magnetic resonance imaging. Results: A total of 1014 participants aged 6 to 23 years (589 male [58.1%]; mean [SD] age, 14.86 [4.79] years) were included from 5 geographic locations. Sparse-partial least squares analysis was used to describe a negative association of arsenic exposure with executive function (r = -0.12 [P = 5.4 × 10-4]), brain structure (r = -0.20 [P = 1.8 × 10-8]), and functional connectivity (within network, r = -0.12 [P = 7.5 × 10-4]; between network, r = -0.23 [P = 1.8 × 10-10]). Alterations in executive function were partially mediated by GMV (b = -0.004 [95% CI, -0.007 to -0.002]) and within-network functional connectivity (b = -0.004 [95% CI, -0.008 to -0.002]). Socioeconomic status and body mass index moderated the association between arsenic and GMV, such that the association was strongest in participants with lower socioeconomic status and body mass index. Conclusions and Relevance: The findings of this cross-sectional study suggest that low-level arsenic exposure was associated with alterations in executive functioning and underlying brain correlates. These results indicate potential detrimental consequences of arsenic exposure that are below the currently recommended guidelines and may extend beyond endemic risk areas. Precision medicine approaches to study global mental health vulnerabilities highlight widespread but potentially modifiable risk factors and a mechanistic understanding of the impact of low-level arsenic exposure on brain development.

Indexed as

ArsenicBrain DiseasesAdolescentBrainChildCohort StudiesCross-Sectional StudiesExecutive FunctionHumansMaleYoung AdultArsenic

Identifiers

PMID37171822
PMCPMC10182429
OpenAlexW4376226611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.